Registration number: 14722555

Heartvet Solutions Limited

Contents

Abridged Balance Sheet	1 to 2
Notes to the Unaudited Abridged Financial Statements	3 to 4

Heartvet Solutions Limited

(Registration number: 14722555)
Abridged Balance Sheet as at 31 March 2025

	Note	2025 £	2024 £
Fixed assets
Tangible assets	4	29,199	25,037
Current assets
Stocks	5	20,383	49,338
Debtors		53,024	50,777
Cash at bank and in hand		62,775	115,816
		136,182	215,931
Creditors: Amounts falling due within one year		(55,798)	(94,986)
Net current assets		80,384	120,945
Total assets less current liabilities		109,583	145,982
Provisions for liabilities		(3,102)	(1,123)
Net assets		106,481	144,859
Capital and reserves
Called up share capital		400	400
Profit and loss account		106,081	144,459
Total equity		106,481	144,859

For the financial year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

	The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and
	The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime and the option not to file the Profit and Loss Account has been taken.

All of the company’s members have consented to the preparation of an Abridged Profit and Loss Account and an Abridged Balance Sheet in accordance with Section 444(2A) of the Companies Act 2006.

Heartvet Solutions Limited

(Registration number: 14722555)
Abridged Balance Sheet as at 31 March 2025

Approved and authorised by the Board on 26 November 2025 and signed on its behalf by:
 

Mrs J Harris

Director

Mr D Dickson

Director

Heartvet Solutions Limited

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 March 2025

1	General information

The company is a private company limited by share capital, incorporated in England & Wales.

The address of its registered office is:
Waldenfields
Whitestone
Exeter
Devon
EX4 2HP

These financial statements were authorised for issue by the Board on 26 November 2025.

2	Accounting policies

Statement of compliance

These abridged financial statements were prepared in accordance with Financial Reporting Standard 102 Section 1A 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006.

Basis of preparation

These abridged financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Tax

The tax expense for the period comprises current and deferred tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Deferred tax is recognised on temporary differences arising between the tax bases of assets and liabilities and their carrying amounts in the financial statements and on unused tax losses or tax credits in the company. Deferred income tax is determined using tax rates and laws that have been enacted or substantively enacted by the reporting date.

The carrying amount of deferred tax assets are reviewed at each reporting date and a valuation allowance is set up against deferred tax assets so that the net carrying amount equals the highest amount that is more likely than not to be recovered based on current or future taxable profit.

Tangible assets

Tangible assets are stated in the statement of financial position at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class	Depreciation method and rate
Plant & machinery	25% Straight line
Office equipment	25% Straight line

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to sell.

Heartvet Solutions Limited

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 March 2025

3	Staff numbers

The average number of persons employed by the company (including directors) during the year, was 6 (2024 - 2).

4	Tangible assets

	Total £
Cost or valuation
At 1 April 2024	33,383
Additions	18,134
Disposals	(2,185)
At 31 March 2025	49,332
Depreciation
At 1 April 2024	8,346
Charge for the year	12,333
Eliminated on disposal	(546)
At 31 March 2025	20,133
Carrying amount
At 31 March 2025	29,199
At 31 March 2024	25,037

5

Stocks

	2025 £	2024 £
Stock	20,383	49,338